Germany Cannabidiol Market Size, Share, and COVID-19 Impact Analysis, By Source Type (Hemp and Marijuana), By Sales Type (B2B and B2C), and Germany Cannabidiol Market Insights, Industry Trend, Forecasts to 2035

Germany Cannabidiol Market Forecasts to 2035

• The Germany Cannabidiol Market Size Was Estimated at USD 16.9 Million in 2024
• The Germany Cannabidiol Market Size is Expected to Grow at a CAGR of around 18.16% from 2025 to 2035
• The Germany Cannabidiol Market Size is Expected to Reach USD 105.9 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the Germany Cannabidiol Market Size is Anticipated to Reach USD 105.9 Million by 2035, Growing at a CAGR of 18.16% from 2025 to 2035. Germany's ongoing product legalisation, rising health and wellness trends, the introduction of a wide range of products, notable advancements in e-commerce, and increased consumer information, the market development.

Market Overview

The Germany cannabidiol market refers to a non-psychoactive cannabis substance used to treat inflammation, anxiety, neuropathic pain, and seizures. Its medicinal properties, which come from hemp or cannabis plants, have increased its appeal in the German consumer and healthcare industries. Due to rising consumer interest in health benefits and the emergence of a wide range of product options, such as edibles, topicals, beverages, and pet care products, the Germany cannabidiol industry is expanding quickly. The growth of e-commerce has increased accessibility and sales by expanding the market reach. By guaranteeing product quality, safety, and transparency, legalisation and regulatory frameworks have legitimised the industry and increased consumer trust. The legal structure supports producers' lab-tested products and promotes a continuous stigma reduction, both of which must increase public acceptability. The public's desire for cannabidiol as an alternative to treating inflammation, anxiety, and sleep issues is being driven by the societal movement towards natural, holistic health treatments. With businesses introducing specialised items designed to meet particular demands, the rivalry is getting fiercer and fiercer. Due to the infinite variety of goods available, consumers are experiencing less choice paralysis and can interact with cannabidiol more frequently. Both rising consumption and the frequency of new product development point to a promising future for the Germany cannabidiol sector.

Report Coverage

This research report categorizes the market for the Germany cannabidiol market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Germany cannabidiol market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Germany cannabidiol market.

Driving Factors

The German market for cannabidiol is being driven by customers' increasing knowledge of the drug's therapeutic advantages for conditions like anxiety, inflammation, and sleep disturbances. Consumer confidence is increased by strict rules and legislation, which guarantee product safety and quality. Many tastes are satisfied by the range of products and applications for cannabidiol, and e-commerce expands market access and opportunity. The market is expanding as a result of societal shifts towards natural, holistic health alternatives, which also increase demand, foster innovation, and attract new companies.

Restraining Factors

The cannabidiol industry is facing increasing challenges due to complicated regulations in various jurisdictions, particularly those relating to food and medicine categories, unapproved items, misleading information, varying customer understanding, and product pricing. These barriers restrict innovation, trust, and accessibility, all of which in turn restrict the overall growth potential of the cannabis sector. These factors hamper the Germany cannabidiol market during the forecast period.

Market Segmentation

The Germany cannabidiol market share is classified into source type and sales type

• The hemp segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Germany cannabidiol market is segmented by source type into hemp and marijuana. Among these, the hemp segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This sector is anticipated to grow at the quickest rate due to rising consumer awareness of health benefits and increased demand from the pharmaceutical industry. Additionally, the legalisation of medical cannabis is anticipated to raise consumer disposable income, which in turn is likely to enhance demand for cannabidiol in the pharmaceutical industry. Oils, tinctures, concentrates, capsules, topical applications like salves, lip balms, and lotions, as well as consumables like coffee, chocolate, gum, candies, and baked goods, are the products that require CBD the most.  

• The B2B segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Germany cannabidiol market is segmented by sales type into B2B and B2C. Among these, the B2B segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. A growing number of wholesalers are entering the market, and the growing demand for CBD oil as a raw ingredient. The potential supply has also grown as a result of the legalization of CBD products in some nations and the emergence of new consumer markets.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Germany cannabidiol market and a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• DEMECAN
• Cansativa GmbH
• Sanity Group
• Cantourage Group
• Bloomwell Group
• SynBiotic SE
• AlephSana GmbH
• Cannamedical Pharma GmbH
• LIO Pharmaceuticals GmbH
• Herbliz Berlin / NGP Berlin
• Others

Key Target Audience

• Investors
• Market players
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Germany, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Germany cannabidiol market based on the below-mentioned segments:

Germany Cannabidiol Market, By Source Type

• Hemp
• Marijuana

Germany Cannabidiol Market, By Sales Type

• B2B
• B2C